[HTML][HTML] Diabetic cardiomyopathy: where we are and where we are going

WS Lee, J Kim - The Korean journal of internal medicine, 2017 - ncbi.nlm.nih.gov
The global burden of diabetes mellitus and its related complications are currently increasing.
Diabetes mellitus affects the heart through various mechanisms including microvascular …

[HTML][HTML] Diabetic cardiomyopathy: Pathophysiology, diagnostic evaluation and management

JM Pappachan, GI Varughese, R Sriraman… - World journal of …, 2013 - ncbi.nlm.nih.gov
Diabetes affects every organ in the body and cardiovascular disease accounts for two-thirds
of the mortality in the diabetic population. Diabetes-related heart disease occurs in the form …

Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure

F Soga, H Tanaka, K Tatsumi, Y Mochizuki… - Cardiovascular …, 2018 - Springer
Background The objective of this study was to investigate the impact of sodium glucose
cotransporter type 2 (SGLT2) inhibitors on left ventricular (LV) diastolic function of type 2 …

Diabetic cardiomyopathy: Clinical phenotype and practice

X Zhao, S Liu, X Wang, Y Chen, P Pang… - Frontiers in …, 2022 - frontiersin.org
Diabetic cardiomyopathy (DCM) is a pathophysiological condition of cardiac structure and
function changes in diabetic patients without coronary artery disease, hypertension, and …

[HTML][HTML] Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2α-Stat3 pathway in diabetic cardiomyopathy

C Liu, Y Han, X Gu, M Li, Y Du, N Feng, J Li, S Zhang… - Redox Biology, 2021 - Elsevier
Diabetes disrupts mitochondrial function and often results in diabetic cardiomyopathy
(DCM). Paeonol is a bioactive compound that has been reported to have pharmacological …

The microRNA in ventricular remodeling: the miR-30 family

X Zhang, S Dong, Q Jia, A Zhang, Y Li, Y Zhu… - Bioscience …, 2019 - portlandpress.com
Ventricular remodeling (VR) is a complex pathological process of cardiomyocyte apoptosis,
cardiac hypertrophy, and myocardial fibrosis, which is often caused by various …

Gingerol, a natural antioxidant, attenuates hyperglycemia and downstream complications

KS Alharbi, MS Nadeem, O Afzal, SI Alzarea… - Metabolites, 2022 - mdpi.com
Hyperglycemia is seen in approximately 68 percent of patients admitted to a medical
intensive care unit (ICU). In many acute circumstances, such as myocardial infarction, brain …

An update on oxidative stress-mediated organ pathophysiology

K Rashid, K Sinha, PC Sil - Food and chemical toxicology, 2013 - Elsevier
Exposure to environmental pollutants and drugs can result in pathophysiological situations
in the body. Research in this area is essential as the knowledge on cellular survival and …

[HTML][HTML] Exercise prevents cardiac injury and improves mitochondrial biogenesis in advanced diabetic cardiomyopathy with PGC-1α and Akt activation

H Wang, Y Bei, Y Lu, W Sun, Q Liu, Y Wang… - Cellular physiology and …, 2015 - karger.com
Background/Aims: Diabetic cardiomyopathy (DCM) represents the major cause of morbidity
and mortality among diabetics. Exercise has been reported to be effective to protect the …

[HTML][HTML] Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate

AM Al Hroob, MH Abukhalil, OE Hussein… - Biomedicine & …, 2019 - Elsevier
Cardiovascular complications are considered one of the leading causes of morbidity and
mortality among diabetic patients. Diabetic cardiomyopathy (DCM) is a type of …